Accretion Pharmaceuticals IPO GMP
Accretion Pharmaceuticals IPO GMP ₹0 ( 0.00% Returns) [21 May 2025]
Accretion Pharmaceuticals IPO GMP is completed on 21 May 2025 at ₹0.00, estimating a premium of 0.00% listing gains per share.
We updated the active GMP trend of Accretion Pharmaceuticals IPO shares for the last 12 days on the basis of Grey market activities. The highest Accretion Pharmaceuticals IPO GMP ever recorded was ₹20 on 12 May 2025, estimating a premium of 19.80%, and the lowest GMP was ₹0 on 21 May 2025, estimating a premium of 0.00%.
Accretion Pharmaceuticals IPO GMP started on 10 May 2025 at ₹0. Check the latest GMP updates below.
We are updating the active GMP trend of Accretion Pharmaceuticals IPO shares for the last 12 days based on Grey market activities. The highest Accretion Pharmaceuticals IPO GMP ever recorded was ₹20 on 12 May 2025, estimating a premium of 19.80%, and the lowest GMP was ₹0 on 21 May 2025, estimating a premium of 0.00%.
As of today, the Accretion Pharmaceuticals IPO GMP activities have not started yet. Once they start, we will update the latest GMP and Subject to Sauda rates daily. Please check back soon for updates.
We update the active GMP trend of Accretion Pharmaceuticals IPO shares for the last 12 days based on Grey market activities. The highest Accretion Pharmaceuticals IPO GMP ever recorded was ₹20 on 12 May 2025, estimating a premium of 19.80%, and the lowest GMP was ₹0 on 21 May 2025, estimating a premium of 0.00%.
As of today, the Accretion Pharmaceuticals IPO GMP rate stands at ₹0, last updated on 21 May 2025. Shares of Accretion Pharmaceuticals IPO are listed on NSE EMERGE on 21 May 2025. On NSE, shares are listed at ₹79.00 at a discount of -21.78%.
As per the last available grey market premium price, shares of Accretion Pharmaceuticals IPO are expected to list at ₹101 at a profit/loss of 0.00%. So the iporeturns GMP accuracy of Accretion Pharmaceuticals IPO is 78.22% on NSE.
Accretion Pharmaceuticals IPO GMP Grey Market Premium Live Updates [21 May 2025]
| GMP Date [Year 2025] |
IPO GMP (on ₹101) |
Subto Sauda (Retail/NII) (₹) |
Est. Listing + Gains |
|---|---|---|---|
|
21 May (Listing) |
₹0 | – | ₹101 (0.00%) |
| 20 May | ₹0 | – | ₹101 (0.00%) |
|
19 May (Allotment) |
₹0 | – | ₹101 (0.00%) |
| 18 May | ₹0 | – | ₹101 (0.00%) |
| 17 May | ₹0 | – | ₹101 (0.00%) |
|
16 May (Close) |
₹0 | – | ₹101 (0.00%) |
| 15 May | ₹0 | – | ₹101 (0.00%) |
|
14 May (Open) |
₹0 | – | ₹101 (0.00%) |
| 13 May | ₹6 | ₹4500 | ₹107 (+5.94%) |
| 12 May | ₹20 | ₹15000 | ₹121 (+19.80%) |
| 11 May | ₹18 | ₹14000 | ₹119 (+17.82%) |
| 10 May | ₹0 | – | ₹101 (0.00%) |
Important Notice: The Accretion Pharmaceuticals IPO GMP Grey market premium and Subject to Sauda rates shown above are based on news related to the Grey Market. We iporeturns.com do not deal, trade and recommend to trade in the grey market. These GMP rates are added only for educational purposes.
What is Accretion Pharmaceuticals IPO Grey Market Premium?
The Accretion Pharmaceuticals IPO GMP (Grey Market Premium) is the premium price on the issue price of an upcoming IPO, traded in the grey market prior to its listing. This GMP reflects the expected listing gains of an IPO on its listing day 21 May 2025. Accretion Pharmaceuticals IPO grey market premium is ₹0, this means that shares are expected to list at a premium of 0.00%. But it is not an official metric to trust and invest. Always consider all factors before investing in Accretion Pharmaceuticals IPO and make a decision to invest or not.
Accretion Pharmaceuticals Limited IPO (Accretion Pharmaceuticals IPO) Overview
| IPO Name | Accretion Pharmaceuticals Limited IPO |
| IPO Status | Listed on NSE at INR 79 (-21.78%) |
| IPO Open Date | 14 May 2025 |
| IPO Close Date | 16 May 2025 |
| Face Value | ₹10 Per Equity Share |
| One Lot Size | 1200 Equity Shares |
| Total Issue | 29,46,000 Shares (worth up to ₹29.75 Crore Rs) |
| Fresh Issue | 29,46,000 Shares (worth up to ₹29.75 Crore Rs) |
| Issue Type | Book Building Issue |
| IPO Listing | NSE EMERGE |
| Retail Portion | Up to 35% of Net Issue |
| NII Portion | Up to 15% of Net Issue |
| Net QIB Portion | Up to 20% of Net Issue |
| Anchor Portion | Up to 30% of Net Issue |
| DRHP Draft Prospectus | View DRHP |
| RHP Draft Prospectus | View RHP |
| Anchor Investors List | View List |
Accretion Pharmaceuticals IPO Important Dates
The following table gives all important events and their timelines for Accretion Pharmaceuticals IPO.
| Anchor Investors Bid Date | 13 May 2025 |
| IPO Open Date | 14 May 2025 |
| IPO Close Date and Time | 16 May 2025 at 3:15 PM |
| Basis of Allotment | 19 May 2025 at 9:00 PM |
| Refunds | 20 May 2025 |
| Credit to DEMAT | 20 May 2025 |
| IPO Listing Date | 21 May 2025 |
About Accretion Pharmaceuticals Limited Company
The Accretion Pharmaceuticals Limited company was founded in year 2012, by Mr. Harshad Nanubhai Rathod, Mr. Vivek Ashok Kumar Patel, Mr. Mayur Popatlal Sojitra and Mr. Hardik Mukundbhai Prajapati. They came together to establish a pharmaceutical manufacturing unit, with vision to provide health care products that match international quality standards at competitive pricing. The Company’s manufacturing facility is currently located in Ahmedabad, Sanand, Gujarat.
At present, the company is engaged in the business of manufacturing and marketing of Tablets, Capsules, Oral Liquid, External Preparations (Ointment, Cream, Gel, Lotion, Medicated Shampoo, Mouthwash, Dusting Powder), And Oral Powder (Sachet, Dry Syrup) etc. Apart from manufacturing products for direct sales, it also manufactures various pharmaceutical products for different marketers on loan license or contract manufacturing basis. Its business is majorly carried out on a principle-to-principle basis with different marketers.
Accretion Pharmaceuticals IPO GMP Grey Market premium FAQs
What is Accretion Pharmaceuticals IPO GMP rate today?
As of 21 May 2025, the Accretion Pharmaceuticals IPO GMP rate stands at ₹0, and is expected to list at a premium/discount of 0.00%.
What is Accretion Pharmaceuticals IPO Subject to Sauda today?
Accretion Pharmaceuticals IPO Subject to Sauda rates are ₹ for Retail/NII as of .
What is the Accretion Pharmaceuticals IPO Expected Returns range?
Accretion Pharmaceuticals IPO expected returns are in the range of 19.80% to 0.00%.
What are the actual Accretion Pharmaceuticals IPO returns?
On BSE, shares are listed at ₹ at a premium/discount of %. On NSE, shares are listed at ₹79.00 at a premium/discount of -21.78%.
What is the Accretion Pharmaceuticals IPO GMP Accuracy?
The iporeturns GMP accuracy of Accretion Pharmaceuticals IPO is 78.22% on NSE.